This article "NSD2 targeting reverses plasticity and drug resistance in prostate cancer" is published in Nature. Author: Jia J. Li Journal: Nature Year: 2025 Podcast type: Short The authors are: Jia J. LiAlessandro VasciaveoDimitris KaragiannisZhen SunKristjan H. GretarssonXiao ChenOuathek OuerfelliFabio SocciarelliZiv FrankensteinHanyang DongMin ZouWei YuanGuangli YangGabriel M. AizenmanTania PannelliniXinjing XuHimisha BeltranYu ChenKevin GardnerBrian D. RobinsonJohann de BonoOr GozaniCory Abate-ShenMark A. RubinMassimo LodaCharles L. SawyersAndrea CalifanoChao LuMichael M. Shen Affiliations: Jia J. Li, Cory Abate-Shen, Andrea Califano, Michael M. Shen, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Jia J. Li, Alessandro Vasciaveo, Cory Abate-Shen, Andrea Califano, Michael M. Shen, Department of Systems Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Jia J. Li, Dimitris Karagiannis, Kristjan H. Gretarsson, Xiao Chen, Chao Lu, Michael M. Shen, Department of Genetics and Development, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Jia J. Li, Cory Abate-Shen, Michael M. Shen, Department of Urology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Jia J. Li, Alessandro Vasciaveo, Dimitris Karagiannis, Kristjan H. Gretarsson, Xiao Chen, Ziv Frankenstein, Min Zou, Cory Abate-Shen, Andrea Califano, Chao Lu, Michael M. Shen, Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Alessandro Vasciaveo, Gabriel M. Aizenman, Center for Data Science and Artificial Intelligence, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA Alessandro Vasciaveo, Gabriel M. Aizenman, Center for Therapeutics Discovery, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA Alessandro Vasciaveo, Gabriel M. Aizenman, Cancer Genome and Epigenetics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA Zhen Sun, Yu Chen, Charles L. Sawyers, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA Ouathek Ouerfelli, Guangli Yang, Organic Synthesis Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA Fabio Socciarelli, Tania Pannellini, Brian D. Robinson, Massimo Loda, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA Ziv Frankenstein, Kevin Gardner, Cory Abate-Shen, Department of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Hanyang Dong, Or Gozani, Department of Biology, Stanford University, Stanford, CA, USA Min Zou, Cory Abate-Shen, Department of Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Wei Yuan, Johann de Bono, Division of Clinical Studies, The Institute of Cancer Research, London, UK Himisha Beltran, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Yu Chen, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Mark A. Rubin, Department of Biomedical Research, Bern Center for Precision Medicine, University of Bern, Bern, Switzerland Massimo Loda, Nuffield Department of Surgical Sciences, Lincoln College, University of Oxford, Oxford, UK Charles L. Sawyers, Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA Andrea Califano, Department of Biomedical Informatics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA Andrea Califano, Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA